SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-014646
Filing Date
2023-03-02
Accepted
2023-03-02 16:18:53
Documents
1
Period of Report
2023-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5464
  Complete submission text file 0001209191-23-014646.txt   6898
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Issuer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 28 TUDOR ROSE TERRACE MAHWAH NJ 07430
Business Address
Tarriff Scott (Reporting) CIK: 0001469124 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36306 | Film No.: 23699209